Evidence map›Paper›PMID 19523929›Full record

ArticleBrain research2009

Immediate neuronal preconditioning by NS1619.

Tamás Gáspár, Ferenc Domoki, Laura Lenti, Prasad V G Katakam, James A Snipes, Ferenc Bari, David W Busija

Abstract read
In one paragraph

Article in Brain research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. BKPharmaceutics · 2022
    Article
  2. Luteolin-Induced Activation of Mitochondrial BKAntioxidants (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Expression and Activation of BKFrontiers in cardiovascular medicine · 2018
    Article
  11. Preconditioning with the BKAmerican journal of physiology. Heart and circulatory physiology · 2017
    Article
  12. Review
  13. Review
  14. Mitochondrial BKCa channel.Frontiers in physiology · 2015
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tamás GáspárDepartment of Physiology and Pharmacology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA. tamas74@freemail.hu
Ferenc Domoki
Laura Lenti
Prasad V G Katakam
James A Snipes
Ferenc Bari
David W Busija
Wake Forest University · USUniversity of Szeged · HU

Funding

Mitochondrial Influences on Cerebral ArteriesR01HL093554 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BUSIJA, DAVID W · 2009 to 2018
$3.3M
Potassium Channel Dysfunction in Cerebral ArteriesR01HL077731 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BUSIJA, DAVID W · 2004 to 2013
$3.2M
REGULATION OF CEREBRAL BLOOD FLOWR01HL030260 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BUSIJA, DAVID W · 1986 to 2010
$2.9M
Endothelial Dysfunction in Insulin ResistanceR01HL065380 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BUSIJA, DAVID W · 2002 to 2010
$2.5M
NHLBI NIH HHS HL-030260NHLBI NIH HHS HL-065380NHLBI NIH HHS HL-077731NHLBI NIH HHS R01 HL030260NHLBI NIH HHS R01 HL065380NHLBI NIH HHS R01 HL077731NHLBI NIH HHS R01 HL093554
6 · The paper itself

Abstract

The objectives of our present experiments were to determine whether the BK(Ca) channel agonist NS1619 is able to induce immediate preconditioning in cultured rat cortical neurons and to elucidate the role of BK(Ca) channels in the initiation of immediate preconditioning. NS1619 depolarized mitochondria and increased reactive oxygen species (ROS) generation, but neither of these effects was inhibited by BK(Ca) channel antagonists. NS1619 also activated the extracellular signal-regulated kinase signaling pathways. One-hour treatment with NS1619 induced immediate protection against glutamate excitotoxicity (viability 24 h after glutamate exposure: control, 58.45+/-0.95%; NS1619 50 microM, 78.99+/-0.90%; NS1619 100 microM, 86.89+/-1.20%; NS1619 150 microM, 93.23+/-1.23%; mean+/-SEM; p<0.05 vs. control; n=16-32). Eliminating ROS during the preconditioning phase effectively blocked the development of cytoprotection. In contrast, the BK(Ca) channel blockers iberiotoxin and paxilline, the phosphoinositide 3-kinase inhibitor wortmannin, the protein kinase C blocker chelerythrine, and the mitogen activated protein kinase antagonist PD98059 were unable to antagonize the immediate neuroprotective effect. Finally, preconditioning with NS1619 reduced the calcium load and ROS surge upon glutamate exposure and increased superoxide dismutase activity. Our results indicate that NS1619 is an effective inducer of immediate neuronal preconditioning, but the neuroprotective effect is independent of the activation of BK(Ca) channels.

Indexed as

AnimalsBenzimidazolesBrainCalcium Channel BlockersCalcium SignalingCells, CulturedCytoprotectionEnzyme InhibitorsGlutamic AcidLarge-Conductance Calcium-Activated Potassium ChannelsMembrane Potential, MitochondrialNeuronsNeuroprotective AgentsNeurotoxinsOxidative StressRatsBenzimidazolesCalcium Channel BlockersEnzyme InhibitorsGlutamic AcidLarge-Conductance Calcium-Activated Potassium ChannelsNeuroprotective AgentsNeurotoxinsNS 1619Reactive Oxygen SpeciesSuperoxide Dismutase

Identifiers

PMID19523929
PMCPMC2744349
OpenAlexW2000342449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.